We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL) (DELLA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00515957
Recruitment Status : Withdrawn
First Posted : August 14, 2007
Last Update Posted : April 16, 2012
The Methodist Hospital System
Texas Children's Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Stephen Gottschalk, Baylor College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : August 2010
  Study Completion Date : August 2010